BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2805179)

  • 1. Pyrrolidine derivatives as inhibitors of platelet aggregation induced by platelet activating factor.
    Danyoshi C; Terao Y; Achiwa K; Okumura H; Kurihara T; Matsuura A; Kobayashi F
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1969-70. PubMed ID: 2805179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation induced by platelet-activating factor is suppressed by cystine protease inhibitor.
    Takano H; Kawaguchi H; Iizuka K; Yasuda H
    Biochem Med Metab Biol; 1991 Feb; 45(1):41-7. PubMed ID: 2015107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erbstatin blocks platelet activating factor-induced protein-tyrosine phosphorylation, polyphosphoinositide hydrolysis, protein kinase C activation, serotonin secretion and aggregation of rabbit platelets.
    Salari H; Duronio V; Howard SL; Demos M; Jones K; Reany A; Hudson AT; Pelech SL
    FEBS Lett; 1990 Apr; 263(1):104-8. PubMed ID: 1691984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G; Stewart AG
    Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF.
    Grigoriadis G; Stewart AG
    Br J Pharmacol; 1992 Sep; 107(1):73-7. PubMed ID: 1330167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet activity of some prenylflavonoids.
    Lin CN; Shieh WL; Ko FN; Teng CM
    Biochem Pharmacol; 1993 Jan; 45(2):509-12. PubMed ID: 8435100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.
    Bin Z; Kun L
    Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between platelet-aggregating response and vasoconstrictive response to platelet activating factor.
    Michibayashi T
    J Smooth Muscle Res; 1999 Aug; 35(4):111-24. PubMed ID: 10647808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
    Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
    Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet aggregation activity of diterpene alkaloids from Spiraea japonica.
    Li L; Shen YM; Yang XS; Zuo GY; Shen ZQ; Chen ZH; Hao XJ
    Eur J Pharmacol; 2002 Aug; 449(1-2):23-8. PubMed ID: 12163102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
    Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
    Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the actions of some platelet-activating factor antagonists on platelets and aortic smooth muscles.
    Teng CM; Yu SM; Ko FN; Chen CC; Wang WC; Chen KY; Huang YL; Huang TF
    Eur J Pharmacol; 1991 Nov; 205(2):151-6. PubMed ID: 1812005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive inhibition of tritium-labeled platelet-activating factor binding to rabbit platelet membranes by amiloride and amiloride analogs.
    Hwang SB
    Biochem Biophys Res Commun; 1989 Aug; 163(1):165-71. PubMed ID: 2549986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating-factor-induced serum-albumin release from rabbit platelets in the absence of calcium.
    Bette-Bobillo P; Bienvenue A
    Eur J Biochem; 1988 Nov; 177(3):643-7. PubMed ID: 3197724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator.
    Hofmann B; Ostermann G; Hoffmann A; Klöcking HP; Kertscher HP
    Biomed Biochim Acta; 1988; 47(10-11):S157-60. PubMed ID: 3248103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study on inhibitory effect of rutin against platelet activation induced by platelet activating factor in rabbits].
    Chen WM; Jin M; Wu W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Apr; 22(4):283-5. PubMed ID: 12584792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-platelet activating factor property of Rubia cordifolia Linn.
    Tripathi YB; Pandey S; Shukla SD
    Indian J Exp Biol; 1993 Jun; 31(6):533-5. PubMed ID: 8406601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
    Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM
    Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factor.
    Yamada T; Tomioka K; Saito M; Horie M; Mase T; Hara H; Nagaoka H
    Arch Int Pharmacodyn Ther; 1990; 308():123-36. PubMed ID: 2099131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.